These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 91227)

  • 1. Evidence for an HLA-linked resistance gene in Buerger's disease.
    de Moerloose P; Jeannet M; Mirimanoff P; Bouvier CA
    Tissue Antigens; 1979 Aug; 14(2):169-73. PubMed ID: 91227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA in Buerger's disease.
    Numano F; Sasazuki T; Koyama T; Shimokado K; Takeda Y; Nishimura Y; Mutoh M
    Exp Clin Immunogenet; 1986; 3(4):195-200. PubMed ID: 3274054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics of peripheral arteriopathies.
    Mehra NK; Jaini R
    Clin Hemorheol Microcirc; 2000; 23(2-4):225-32. PubMed ID: 11321444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA-A9 and HLA-B5 with Buerger's disease.
    McLoughlin GA; Helsby CR; Evans CC; Chapman DM
    Br Med J; 1976 Nov; 2(6045):1165-6. PubMed ID: 990826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunological aspects of thromboangiitis obliterans (Buerger's disease).
    Smolen JS; Youngchaiyud U; Weidinger P; Kojer M; Endler AT; Mayr WR; Menzel EJ
    Clin Immunol Immunopathol; 1978 Oct; 11(2):168-77. PubMed ID: 367656
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenetic analysis of Buerger's disease in India.
    Jaini R; Mandal S; Khazanchi RK; Mehra NK
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S283-5. PubMed ID: 9951831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICA gene polymorphism in Takayasu's arteritis and Buerger's disease.
    Kimura A; Kobayashi Y; Takahashi M; Ohbuchi N; Kitamura H; Nakamura T; Satoh M; Sasaoka T; Hiroi S; Arimura T; Akai J; Aerbajinai W; Yasukochi Y; Numano F
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S107-13; discussion S115. PubMed ID: 9951809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
    Papa M; Bass A; Adar R; Halperin Z; Schneiderman J; Becker CG; Brautbar H; Mozes E
    Surgery; 1992 May; 111(5):527-31. PubMed ID: 1598672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II DNA typing in Buerger's disease.
    Aerbajinai W; Tsuchiya T; Kimura A; Yasukochi Y; Numano F
    Int J Cardiol; 1996 Aug; 54 Suppl():S197-202. PubMed ID: 9119524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology and pathogenesis of Buerger's disease.
    Tanaka K
    Int J Cardiol; 1998 Oct; 66 Suppl 1():S237-42. PubMed ID: 9951825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buerger's disease in two brothers: iliac artery occlusion by thromboangiitis obliterans--case reports.
    Wysokinski WE; Kwiatkowska W; Maslowski L; Witkiewicz W; Kowal-Gierczak B
    Angiology; 1998 May; 49(5):409-14. PubMed ID: 9591534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Population genetics, immunologic evaluation and Buerger's disease. Projection through a personal study comprising 127 cases of juvenile arteriopathy].
    Schmitt J; Schmidt C; Alan C; Haller C; Perrier P
    Bull Acad Natl Med; 1993 Oct; 177(7):1153-62; discussion 1162-4. PubMed ID: 8149255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Buerger's disease, aortitis syndrome and HL-A].
    Yasuda K; Yokota A; Tanabe T
    Nihon Rinsho; 1978 Sep; 36(9):3171-5. PubMed ID: 722915
    [No Abstract]   [Full Text] [Related]  

  • 14. ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger's disease.
    Byun JK; Kim KH; Rha SW; Park Y; Cha JA; Choi SY; Choi BG; Choi CU
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4051-4063. PubMed ID: 34156683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet receptor HPA-1 polymorphism of alphaIIbbeta3 and 807 C/T polymorphism of alpha2beta1 and Buerger's disease.
    Ostojic L; Zelenika D; Zotz RB; Sucker C; Ostojic Z; Loncar R
    Angiology; 2007; 58(2):169-74. PubMed ID: 17495265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboangiitis obliterans: an old disease in need of a new look.
    Adar R; Papa MZ; Schneiderman J
    Int J Cardiol; 2000 Aug; 75 Suppl 1():S167-70; discussion S171-3. PubMed ID: 10980358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells.
    Sun XL; Law BY; de Seabra Rodrigues Dias IR; Mok SWF; He YZ; Wong VK
    Atherosclerosis; 2017 Oct; 265():258-265. PubMed ID: 28864202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buerger's disease and anticardiolipin antibodies.
    Pereira de Godoy JM; Braile DM
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):792-4. PubMed ID: 19455050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboangiitis obliterans (Buerger's disease).
    Mishima Y
    Int J Cardiol; 1996 Aug; 54 Suppl():S185-7. PubMed ID: 9119522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin gene 20210 G-->A and Factor V Arg 506 to Gln mutation in a patient with Buerger's disease--a case report.
    Avcu F; Akar N; Akar E; Beyan C; Yalçin A
    Angiology; 2000 May; 51(5):421-3. PubMed ID: 10826859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.